Balyasny Asset Management L.P. Reduces $51M in American Healthcare REIT, Inc. ($AHR)

Balyasny Asset Management L.P. has cut its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 45.7%, according to its latest Form 13F filing with the SEC. As of the reporting period, the fund sold 985,000 shares, reducing its holdings to 1,168,129 shares valued at approximately $58.9 million.

What Changed in Balyasny's American Healthcare REIT Position

Balyasny Asset Management reduced its stake in American Healthcare REIT from 2,153,129 shares to 1,168,129 shares, a decrease of 985,000 shares. This reduction represents a 45.7% decrease in their position, leaving the fund with a stake valued at around $58.9 million.

Other Institutional Activity in American Healthcare REIT

Other institutional investors have also adjusted their positions in American Healthcare REIT. BlackRock, Inc. increased its holdings by 8,604,835 shares, bringing its total to 28,741,094 shares worth about $1.36 billion, a 42.7% increase. Vanguard Portfolio Management LLC opened a new position with 16,124,024 shares, valued at approximately $760.4 million. State Street Corp added 2,459,374 shares, increasing its stake by 34.7% to 9,545,044 shares valued at $452.5 million. Wellington Management Group LLP added 360,969 shares, a 4.6% increase, resulting in 8,283,787 shares worth about $390.7 million.

American Healthcare REIT, Inc. Stock Down 6.5%

As of Friday, shares of American Healthcare REIT, Inc. (NYSE:AHR) traded near $50.39. The company boasts a market cap of approximately $10.53 billion, with a P/E ratio of 86.3 and a forward P/E of 59.2. The stock's 52-week trading range spans from $35.52 to $54.67, with a 50-day moving average of $49.15 and a 200-day moving average of $47.81. The company maintains a current ratio of 1.005 and a quick ratio of 0.792, alongside a debt-to-equity ratio of 47.614.

Recent Earnings

American Healthcare REIT reported revenue of $2.37 billion, reflecting a growth rate of 20.9%. The company achieved a net margin of 4.2% and a return on equity of 3.5%. Earnings per share were $0.59. The next earnings report is expected on August 6, 2026.

Dividend

The company offers a dividend rate of $1.00 per share, yielding 1.96%. The dividend payout ratio is 169.49%, indicating the portion of earnings paid out as dividends.

Insider Buying and Selling at American Healthcare REIT, Inc.

Several insider transactions have taken place at American Healthcare REIT. On June 1, 2026, Mark Foster, EVP, GC & Secretary, sold 2,000 shares at an average price of $48.32 under a Rule 10b5-1 plan. On April 6, 2026, Danny Prosky acquired 15,924 shares without a specified price, while also selling 8,596 shares at $48.09. Gabriel Willhite, the Chief Operating Officer, sold 6,768 shares, and Stefan K.L. Oh, Chief Investment Officer, sold 3,185 shares on the same day, with no price disclosed.

Analysts Set New Price Targets

Analysts have recently set new price targets for American Healthcare REIT. On June 18, 2026, Scotiabank maintained a 'buy' rating with a $51.00 price target. Keybanc also maintained a 'buy' rating with a $58.00 target on May 28, 2026. RBC Capital followed suit with a 'buy' rating and a $56.00 target on May 26, 2026. The consensus among 13 analysts is a 'strong buy' with a mean target price of $58.23.

About American Healthcare REIT

American Healthcare REIT, Inc., based in Irvine, California, is a self-managed real estate investment trust (REIT) focusing on healthcare facilities. It owns and operates a diverse portfolio, including senior housing, skilled nursing facilities, and outpatient medical buildings across the U.S., U.K., and the Isle of Man. The company is led by CEO Jeffrey T. Hanson and has 121 employees. American Healthcare REIT is committed to maintaining its status as a REIT under U.S. tax law and seeks to acquire income-generating assets while also developing healthcare properties.

Bottom Line

Balyasny Asset Management's reduction in its stake in American Healthcare REIT is a significant move, reflecting the fund's strategic portfolio adjustments. Investors often track such filings to gauge institutional sentiment, although these 13F reports are backward-looking and may not reflect current positions. American Healthcare REIT remains an active player in the healthcare real estate sector, with ongoing institutional interest and a solid analyst outlook.